Adrenal Tumors - Pathogenesis and Therapy
Launched by UNIVERSITY OF WUERZBURG · Apr 29, 2008
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Adrenal Tumors - Pathogenesis and Therapy," is studying adrenal tumors, which are growths that occur in the adrenal glands located on top of the kidneys. These tumors can lead to serious conditions such as Cushing syndrome, Conn syndrome, and pheochromocytoma. The researchers want to better understand how these tumors develop and to evaluate different treatment options for a specific type of adrenal tumor called adrenocortical carcinoma. This study is currently looking for participants of all ages (from infants to adults) who have been diagnosed with an adrenal tumor through imaging tests.
If you or a loved one has been diagnosed with an adrenal tumor, you may be eligible to participate in this trial. The main requirement is that there must be a confirmed adrenal tumor detected by imaging. Participants in this study will have the opportunity to contribute to important research that could improve treatment options for adrenal tumors in the future. Being part of this trial may also provide access to new therapies and close monitoring by healthcare professionals. If you're interested, it's a good idea to talk to your doctor about the details and what participating would involve.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adrenal tumor detected by imaging
- Exclusion Criteria:
About University Of Wuerzburg
The University of Würzburg, a prestigious institution located in Bavaria, Germany, is renowned for its commitment to advancing medical research and education. With a rich history dating back to 1402, the university is home to a diverse range of interdisciplinary research initiatives, particularly in the fields of medicine, life sciences, and pharmacology. As a clinical trial sponsor, the University of Würzburg is dedicated to conducting innovative research that aims to improve patient outcomes and contribute to the global medical community. The institution emphasizes ethical practices, rigorous scientific methodologies, and collaboration with various stakeholders to ensure the integrity and success of its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuerzburg, , Germany
Patients applied
Trial Officials
Martin Fassnacht, MD
Principal Investigator
U of Wuerzburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials